Author

P. Moss

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 4 Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 5 Organism:human· 5 Research Focus:cell type annotation· 3 Research Focus:differential expression· 3 Research Focus:host-pathogen & immune response· 3 Assay:proteomics· 3 Research Focus:cell signaling & trafficking· 1 Assay:flow cytometry· 1

Frequent Co-Authors

J. Zuo· 4 shared B. Hallis· 2 shared C. Stephens· 2 shared F. Aiano· 2 shared G. Amirthalingam· 2 shared H. Pearce· 2 shared J. Begum· 2 shared K. Brown· 2 shared

Activity by Year

2020-2024 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 41 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

4 shared papersImmunology

J. Zuo

Mutual co-authors in cluster

Author profile →

5 papers

Recent·Most cited

Global variation in prior exposure shapes antibody neutralization profiles of SARS-CoV-2 variants up to BA.2.86

S. Turner, G. Amirthalingam, D. Bailey, D. H. Barouch, K. R. Bewley, K. Brown, Y. R. Cao, Y.-W. Chan, S. Charlton, DOVE consortium, N. S. Coombes, B. Hallis, D. D. Ho, F. Jian, N. Lasrado, , D. J. Smith

The paper analyzes antibody neutralization data from multiple countries to assess how prior exposure to SARS-CoV-2 variants affects neutralization profiles of BA.2.86 and its descendants.

bioRxiv · Mar 27, 2024 · PreprintImmunology

Spatial determination and prognostic impact of the fibroblast transcriptome in pancreatic ductal adenocarcinoma

W. Croft, H. Pearce, S. Margielewska-Davies, L. Lim, S. M. Nicol, F. Zayou, D. Blakeway, F. Marcon, S. Powell-Brett, B. Mahon, R. Merard, J. Zuo, G. Middleton, K. Roberts, R. M. Brown, P. Moss

The paper uses spatial transcriptomics and scRNA-Seq to analyze fibroblast subtypes in pancreatic ductal adenocarcinoma, linking their transcriptomes to clinical outcomes and suggesting therapeutic targets.

bioRxiv · Jan 20, 2023Cancer Biology

Immunological imprinting of humoral immunity to SARS-CoV-2 in children

A. C. Dowell, T. Lancaster, R. Bruton, G. Ireland, C. Bentley, P. Sylla, J. Zuo, S. Scott, A. Jardin, J. Begum, T. Roberts, C. Stephens, S. Ditta, R. Shepherdson, A. Powell, , P. Moss

This study examines immune responses to Omicron variants in children, finding weak initial antibody responses that improve with reinfection or vaccination, while cellular immunity remains robust across all groups.

bioRxiv · Jul 26, 2022Immunology

A single episode of CMV reactivation initiates long-term expansion and differentiation of the NK cell repertoire

N. Hassan, S. Eldershaw, C. Stephens, F. Kinsella, C. Craddock, R. Malladi, J. Zuo, P. Moss

bioRxiv · Feb 28, 2022 · PreprintImmunology

Robust SARS-CoV-2-specific T-cell immunity is maintained at 6 months following primary infection

J. Zuo, A. Dowell, H. Pearce, K. Verma, H. Long, J. Begum, F. Aiano, Z. Amin-Chowdhury, B. Hallis, L. Stapley, R. Borrow, E. Linley, S. Ahmad, B. Parker, A. Horsley, , P. Moss

This study shows that SARS-CoV-2-specific T-cell immunity remains robust six months after infection, with response magnitude linked to initial infection severity.

bioRxiv · Nov 1, 2020Immunology